News & Updates

Temporary interruption of adjuvant endocrine therapy (ET) to allow for pregnancy has demonstrated short-term safety, with no increase in risk of breast cancer events, including distant recurrence, in hormone receptor–positive breast cancer survivors who have completed 18–30 months of adjuvant ET.

Treatment success of caesarean scar ectopic pregnancy appears to be higher with hysteroscopic resection than with ultrasound-guided dilation and evacuation (D&E), according to a study.

Good quality surgery conferred a progression-free survival (PFS) benefit for women with ovarian sex cord stromal tumours (SCST) in the first-line setting and on first and second relapse. Chemotherapy, on the other hand, had no impact on survival in the first-line or relapse setting.

Children born to mothers who had contracted hepatitis B virus (HBV) infection before pregnancy appear to be at increased risk of congenital heart diseases (CHDs), as reported in a study.

Women with prenatal depression appears to have an elevated cumulative risk of developing cardiovascular disease (CVD) within 24 months postpartum, with the risk persisting despite the absence of co‐occurring hypertensive disorders of pregnancy, as reported in a study.

Children born to mothers who had depression and/or anxiety during pregnancy appear to have a heightened risk of developing type 1 diabetes, as shown in a study.

Use of a single dose of a new bioadhesive 2% clindamycin vaginal gel in the treatment of bacterial vaginosis appears to result in a rapid resolution of symptoms, with high acceptability among women, as reported in a study.